In addition, PI3K signaling is associated with the regulation of several metabolic effects through its activity on Akt and mTOR, as supported by a shift towards a highly glycolytic phenotype observed in cancer cells by PIK3CA mutations [50]. Here, AKT1 is linked to cancer.